Financial Year |
March 31 2023 |
Monetary Funds |
476,923,936.58 |
Held-for-trading Financial Assets |
348,546,731.99 |
Notes Receivable |
2,782,574.61 |
Accounts Receivable |
320,684,003.28 |
Advances to Suppliers |
49,750,453.79 |
Other Receivables |
77,872,793.33 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
759,428,341.56 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
76,427,628.48 |
Other Current Assets |
109,153,212.09 |
Total Current Assets |
2,291,915,286.57 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,433,592,849.69 |
Investment Properties |
125,370,693.20 |
Fixed Assetes |
1,074,744,585.13 |
Under-construction Projects |
69,624,704.71 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
429,191,470.48 |
R&D expenses |
-- |
Goodwill |
199,189,869.20 |
Long-Term Deferred and Prepaid Expenses |
80,175,137.37 |
Deferred Income Tax Assets |
110,850,184.20 |
Other Non-Current Assets |
17,836,647.83 |
Sub-Total of Non-Current Assets |
4,116,570,986.48 |
Total Assets |
6,408,486,273.05 |
Short-Term Loans |
71,811,155.56 |
Trading Financial liabilities |
-- |
Notes Payable |
332,552,876.00 |
Accounts Payable |
551,549,800.30 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
84,930,882.40 |
Taxes Payable |
37,792,915.97 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
797,455,354.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
61,505,109.32 |
Sub-Total of Current Liabilities |
2,442,186,893.02 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
20,420,103.23 |
Deferred Income Tax Liabilities |
61,370,990.27 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
143,178,373.06 |
Total Liabilities |
2,585,365,266.08 |
Paid-In Capital(Or Share Stock) |
820,869,546.00 |
Capital Surplus |
1,934,286,829.88 |
Surplus Reserve |
249,982,861.96 |
LESS:Treasury Stock |
31,551,199.48 |
Undistributed Profits |
819,585,951.80 |
Minority Stockholder's Interest |
69,424,406.48 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,753,696,600.49 |
Owner's Equity(Stockholder's Equity) |
3,823,121,006.97 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,408,486,273.05 |